Skip to main content

Table 4 Logistic regression for predicting response category “CR or PR” versus “SD or “PD”

From: Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors

  Estimate Std. Error z value Pr(>|z|)
TumorType RCC (reference)
TumorType Melanoma (versus RCC) 1.50 0.50 3.01 0.0026
TumorType NSCLC (versus RCC) −0.13 0.53 −0.25 NS
IHC TPS ≥1% 0.41 0.40 1.03 NS
RNA-seq.L 0.96 0.40 2.43 0.015
RNA-seq.Q 0.21 0.28 0.76 NS